Review




Structured Review

Diagast Inc monoclonal anti-d reagents d-screen
Monoclonal Anti D Reagents D Screen, supplied by Diagast Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+screen/monoclonal+anti+d+d+screen/pm40389221-75-13-16
Average 90 stars, based on 1 article reviews
monoclonal anti-d reagents d-screen - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Agglutination:

Article Title: A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants.
Article Snippet: W e report a new RHD variant allele (RHD 1016G>T, Gly339Val, GenBank Accession No. MF737523, ISBT nomenclature RHD*DEL49.) that was discovered in a Korean male hepatocellular carcinoma patient.. We have performed epitope mapping of the D antigen and analyzed the expected effect of this variation with comparison to two other D weak–expressing variants with an amino acid change in the same position.. Pretransfusion testing of D blood group was performed: two commercial anti-D reagents (Ortho Clinical Diagnostics and Millipore) were used for D and weak-D typing, and results indicated no reactions in both routine D and weak-D testing.

Article Title: The 30th Regional Congress of the ISBT, Bangkok, Thailand, 16-19 Nov, 2019.
Article Snippet: RhD phenotyping was initially routinely performed using two monoclonal anti-D reagents (Clone Rum-1, IgM; Clone TH-28/MS26, IgM/IgG), and then tested using a commercial panel of monoclonal anti-D reagents (D-Screen; Diagast, Loss, France).

Article Title: Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles.
Article Snippet: Funding information Guangdong Basic and Applied Basic Research Foundation, Grant/Award Numbers: 2021A1515012139, 2021A1515012532; National Natural Science Foundation of China, Grant/Award Numbers: 81900184, 82070198; The Key Medical Disciplines and Specialties Program of Guangzhou (2021-2023), Guangdong, China Abstract Background: The molecular basis of the D variant phenotype in the Chinese differs greatly from that of the Caucasian.. Adapting a specific D typing strategy to the spectrum of prevalent RHD variant alleles is necessary.. Study Design and Methods: Blood samples with ambiguous D phenotypes were collected in the Southern Chinese population.

Article Title: Abstracts of the 37th International Congress of the ISBT, Virtual meeting, 4-8 June 2022.
Article Snippet: Further RH1 antigen characterization included an anti-RH1 antibody panel containing nine monoclonal antibodies (D-Screen, Diagast).

Article Title: The need for routine detection of the Asian-type DEL allele in individuals with weak or partial D phenotypes from East and Southeast Asian populations.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82470233; Science and Technology Projects in Guangzhou, Grant/Award Numbers: 202201011823, 2024A03J0442, 2023A03J0545, 2023A03J0552; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2024A1515012995 Abstract Background and Objectives: Among the rare serologically D-negative (D ) individuals in Asia, those carrying the Asian-type DEL allele (RHD*DEL1) can be safely managed as D+ individuals during transfusion and pregnancy.. Recently, some individuals carrying RHD*DEL1, who exhibit serologically weak/partial D phenotypes rather than the serologically D phenotype, have also been described.. Whether anti-D alloimmunization can occur among them was explored.

Article Title: The 36th International ISBT Congress, Virtual meeting, 12-16 December 2020.
Article Snippet: The serological characteristic for the epitope of D antigen was further analyzed by using the commercial panel anti-D reagents (D-Screen, Diagast).

Article Title: RHD alleles contributing to serologically weak D phenotypes in China: A single-centre study over 10 years.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 30371312, 81970168; Research Foundation of Shanghai Municipal Health Commission, China, Grant/ Award Number: 201940442 Abstract Background and Objectives: In cases of serologically weak D phenotypes, RHD genotyping may identify discrepant serotyping results and protect the patient against allogeneic immunization.. This study aimed to conduct a comprehensive analysis of weak D alleles in China.. Materials and Methods: We collected samples carrying weak D antigen during a 10-year period from 2005 to 2014.

Article Title: Reduced RhD antigen expression caused by two novel RHD variant alleles.
Article Snippet: R outine donor screening revealed ambiguous results for RhD blood group typing in two donors.. Donor 1, serologically typed as RhD negative, was positive for exon 3/5 and 10 in routine RHD screening as performed for all RhD-negative donors in Switzerland.. Donor 2 displayed an unusual reaction pattern with the Combi Anti-D Mono-Type antisera (clones LDM3 and ESD1) from Medion Grifols Switzerland.

Saline:

Article Title: A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants.
Article Snippet: W e report a new RHD variant allele (RHD 1016G>T, Gly339Val, GenBank Accession No. MF737523, ISBT nomenclature RHD*DEL49.) that was discovered in a Korean male hepatocellular carcinoma patient.. We have performed epitope mapping of the D antigen and analyzed the expected effect of this variation with comparison to two other D weak–expressing variants with an amino acid change in the same position.. Pretransfusion testing of D blood group was performed: two commercial anti-D reagents (Ortho Clinical Diagnostics and Millipore) were used for D and weak-D typing, and results indicated no reactions in both routine D and weak-D testing.

Article Title: The 30th Regional Congress of the ISBT, Bangkok, Thailand, 16-19 Nov, 2019.
Article Snippet: RhD phenotyping was initially routinely performed using two monoclonal anti-D reagents (Clone Rum-1, IgM; Clone TH-28/MS26, IgM/IgG), and then tested using a commercial panel of monoclonal anti-D reagents (D-Screen; Diagast, Loss, France).

Article Title: Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles.
Article Snippet: Funding information Guangdong Basic and Applied Basic Research Foundation, Grant/Award Numbers: 2021A1515012139, 2021A1515012532; National Natural Science Foundation of China, Grant/Award Numbers: 81900184, 82070198; The Key Medical Disciplines and Specialties Program of Guangzhou (2021-2023), Guangdong, China Abstract Background: The molecular basis of the D variant phenotype in the Chinese differs greatly from that of the Caucasian.. Adapting a specific D typing strategy to the spectrum of prevalent RHD variant alleles is necessary.. Study Design and Methods: Blood samples with ambiguous D phenotypes were collected in the Southern Chinese population.

Article Title: Abstracts of the 37th International Congress of the ISBT, Virtual meeting, 4-8 June 2022.
Article Snippet: Further RH1 antigen characterization included an anti-RH1 antibody panel containing nine monoclonal antibodies (D-Screen, Diagast).

Article Title: The need for routine detection of the Asian-type DEL allele in individuals with weak or partial D phenotypes from East and Southeast Asian populations.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82470233; Science and Technology Projects in Guangzhou, Grant/Award Numbers: 202201011823, 2024A03J0442, 2023A03J0545, 2023A03J0552; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2024A1515012995 Abstract Background and Objectives: Among the rare serologically D-negative (D ) individuals in Asia, those carrying the Asian-type DEL allele (RHD*DEL1) can be safely managed as D+ individuals during transfusion and pregnancy.. Recently, some individuals carrying RHD*DEL1, who exhibit serologically weak/partial D phenotypes rather than the serologically D phenotype, have also been described.. Whether anti-D alloimmunization can occur among them was explored.

Article Title: The 36th International ISBT Congress, Virtual meeting, 12-16 December 2020.
Article Snippet: The serological characteristic for the epitope of D antigen was further analyzed by using the commercial panel anti-D reagents (D-Screen, Diagast).

Article Title: RHD alleles contributing to serologically weak D phenotypes in China: A single-centre study over 10 years.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 30371312, 81970168; Research Foundation of Shanghai Municipal Health Commission, China, Grant/ Award Number: 201940442 Abstract Background and Objectives: In cases of serologically weak D phenotypes, RHD genotyping may identify discrepant serotyping results and protect the patient against allogeneic immunization.. This study aimed to conduct a comprehensive analysis of weak D alleles in China.. Materials and Methods: We collected samples carrying weak D antigen during a 10-year period from 2005 to 2014.

Article Title: Reduced RhD antigen expression caused by two novel RHD variant alleles.
Article Snippet: R outine donor screening revealed ambiguous results for RhD blood group typing in two donors.. Donor 1, serologically typed as RhD negative, was positive for exon 3/5 and 10 in routine RHD screening as performed for all RhD-negative donors in Switzerland.. Donor 2 displayed an unusual reaction pattern with the Combi Anti-D Mono-Type antisera (clones LDM3 and ESD1) from Medion Grifols Switzerland.

Diagnostic Assay:

Article Title: A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants.
Article Snippet: W e report a new RHD variant allele (RHD 1016G>T, Gly339Val, GenBank Accession No. MF737523, ISBT nomenclature RHD*DEL49.) that was discovered in a Korean male hepatocellular carcinoma patient.. We have performed epitope mapping of the D antigen and analyzed the expected effect of this variation with comparison to two other D weak–expressing variants with an amino acid change in the same position.. Pretransfusion testing of D blood group was performed: two commercial anti-D reagents (Ortho Clinical Diagnostics and Millipore) were used for D and weak-D typing, and results indicated no reactions in both routine D and weak-D testing.

Article Title: The 30th Regional Congress of the ISBT, Bangkok, Thailand, 16-19 Nov, 2019.
Article Snippet: RhD phenotyping was initially routinely performed using two monoclonal anti-D reagents (Clone Rum-1, IgM; Clone TH-28/MS26, IgM/IgG), and then tested using a commercial panel of monoclonal anti-D reagents (D-Screen; Diagast, Loss, France).

Article Title: Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles.
Article Snippet: Funding information Guangdong Basic and Applied Basic Research Foundation, Grant/Award Numbers: 2021A1515012139, 2021A1515012532; National Natural Science Foundation of China, Grant/Award Numbers: 81900184, 82070198; The Key Medical Disciplines and Specialties Program of Guangzhou (2021-2023), Guangdong, China Abstract Background: The molecular basis of the D variant phenotype in the Chinese differs greatly from that of the Caucasian.. Adapting a specific D typing strategy to the spectrum of prevalent RHD variant alleles is necessary.. Study Design and Methods: Blood samples with ambiguous D phenotypes were collected in the Southern Chinese population.

Article Title: Abstracts of the 37th International Congress of the ISBT, Virtual meeting, 4-8 June 2022.
Article Snippet: Further RH1 antigen characterization included an anti-RH1 antibody panel containing nine monoclonal antibodies (D-Screen, Diagast).

Article Title: The need for routine detection of the Asian-type DEL allele in individuals with weak or partial D phenotypes from East and Southeast Asian populations.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82470233; Science and Technology Projects in Guangzhou, Grant/Award Numbers: 202201011823, 2024A03J0442, 2023A03J0545, 2023A03J0552; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2024A1515012995 Abstract Background and Objectives: Among the rare serologically D-negative (D ) individuals in Asia, those carrying the Asian-type DEL allele (RHD*DEL1) can be safely managed as D+ individuals during transfusion and pregnancy.. Recently, some individuals carrying RHD*DEL1, who exhibit serologically weak/partial D phenotypes rather than the serologically D phenotype, have also been described.. Whether anti-D alloimmunization can occur among them was explored.

Article Title: The 36th International ISBT Congress, Virtual meeting, 12-16 December 2020.
Article Snippet: The serological characteristic for the epitope of D antigen was further analyzed by using the commercial panel anti-D reagents (D-Screen, Diagast).

Article Title: RHD alleles contributing to serologically weak D phenotypes in China: A single-centre study over 10 years.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 30371312, 81970168; Research Foundation of Shanghai Municipal Health Commission, China, Grant/ Award Number: 201940442 Abstract Background and Objectives: In cases of serologically weak D phenotypes, RHD genotyping may identify discrepant serotyping results and protect the patient against allogeneic immunization.. This study aimed to conduct a comprehensive analysis of weak D alleles in China.. Materials and Methods: We collected samples carrying weak D antigen during a 10-year period from 2005 to 2014.

Article Title: Reduced RhD antigen expression caused by two novel RHD variant alleles.
Article Snippet: R outine donor screening revealed ambiguous results for RhD blood group typing in two donors.. Donor 1, serologically typed as RhD negative, was positive for exon 3/5 and 10 in routine RHD screening as performed for all RhD-negative donors in Switzerland.. Donor 2 displayed an unusual reaction pattern with the Combi Anti-D Mono-Type antisera (clones LDM3 and ESD1) from Medion Grifols Switzerland.

Transfection:

Article Title: A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants.
Article Snippet: W e report a new RHD variant allele (RHD 1016G>T, Gly339Val, GenBank Accession No. MF737523, ISBT nomenclature RHD*DEL49.) that was discovered in a Korean male hepatocellular carcinoma patient.. We have performed epitope mapping of the D antigen and analyzed the expected effect of this variation with comparison to two other D weak–expressing variants with an amino acid change in the same position.. Pretransfusion testing of D blood group was performed: two commercial anti-D reagents (Ortho Clinical Diagnostics and Millipore) were used for D and weak-D typing, and results indicated no reactions in both routine D and weak-D testing.

Article Title: The 30th Regional Congress of the ISBT, Bangkok, Thailand, 16-19 Nov, 2019.
Article Snippet: RhD phenotyping was initially routinely performed using two monoclonal anti-D reagents (Clone Rum-1, IgM; Clone TH-28/MS26, IgM/IgG), and then tested using a commercial panel of monoclonal anti-D reagents (D-Screen; Diagast, Loss, France).

Article Title: Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles.
Article Snippet: Funding information Guangdong Basic and Applied Basic Research Foundation, Grant/Award Numbers: 2021A1515012139, 2021A1515012532; National Natural Science Foundation of China, Grant/Award Numbers: 81900184, 82070198; The Key Medical Disciplines and Specialties Program of Guangzhou (2021-2023), Guangdong, China Abstract Background: The molecular basis of the D variant phenotype in the Chinese differs greatly from that of the Caucasian.. Adapting a specific D typing strategy to the spectrum of prevalent RHD variant alleles is necessary.. Study Design and Methods: Blood samples with ambiguous D phenotypes were collected in the Southern Chinese population.

Article Title: Abstracts of the 37th International Congress of the ISBT, Virtual meeting, 4-8 June 2022.
Article Snippet: Further RH1 antigen characterization included an anti-RH1 antibody panel containing nine monoclonal antibodies (D-Screen, Diagast).

Article Title: The need for routine detection of the Asian-type DEL allele in individuals with weak or partial D phenotypes from East and Southeast Asian populations.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82470233; Science and Technology Projects in Guangzhou, Grant/Award Numbers: 202201011823, 2024A03J0442, 2023A03J0545, 2023A03J0552; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2024A1515012995 Abstract Background and Objectives: Among the rare serologically D-negative (D ) individuals in Asia, those carrying the Asian-type DEL allele (RHD*DEL1) can be safely managed as D+ individuals during transfusion and pregnancy.. Recently, some individuals carrying RHD*DEL1, who exhibit serologically weak/partial D phenotypes rather than the serologically D phenotype, have also been described.. Whether anti-D alloimmunization can occur among them was explored.

Article Title: The 36th International ISBT Congress, Virtual meeting, 12-16 December 2020.
Article Snippet: The serological characteristic for the epitope of D antigen was further analyzed by using the commercial panel anti-D reagents (D-Screen, Diagast).

Article Title: RHD alleles contributing to serologically weak D phenotypes in China: A single-centre study over 10 years.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 30371312, 81970168; Research Foundation of Shanghai Municipal Health Commission, China, Grant/ Award Number: 201940442 Abstract Background and Objectives: In cases of serologically weak D phenotypes, RHD genotyping may identify discrepant serotyping results and protect the patient against allogeneic immunization.. This study aimed to conduct a comprehensive analysis of weak D alleles in China.. Materials and Methods: We collected samples carrying weak D antigen during a 10-year period from 2005 to 2014.

Article Title: Reduced RhD antigen expression caused by two novel RHD variant alleles.
Article Snippet: R outine donor screening revealed ambiguous results for RhD blood group typing in two donors.. Donor 1, serologically typed as RhD negative, was positive for exon 3/5 and 10 in routine RHD screening as performed for all RhD-negative donors in Switzerland.. Donor 2 displayed an unusual reaction pattern with the Combi Anti-D Mono-Type antisera (clones LDM3 and ESD1) from Medion Grifols Switzerland.

Expressing:

Article Title: A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants.
Article Snippet: W e report a new RHD variant allele (RHD 1016G>T, Gly339Val, GenBank Accession No. MF737523, ISBT nomenclature RHD*DEL49.) that was discovered in a Korean male hepatocellular carcinoma patient.. We have performed epitope mapping of the D antigen and analyzed the expected effect of this variation with comparison to two other D weak–expressing variants with an amino acid change in the same position.. Pretransfusion testing of D blood group was performed: two commercial anti-D reagents (Ortho Clinical Diagnostics and Millipore) were used for D and weak-D typing, and results indicated no reactions in both routine D and weak-D testing.

Article Title: The 30th Regional Congress of the ISBT, Bangkok, Thailand, 16-19 Nov, 2019.
Article Snippet: RhD phenotyping was initially routinely performed using two monoclonal anti-D reagents (Clone Rum-1, IgM; Clone TH-28/MS26, IgM/IgG), and then tested using a commercial panel of monoclonal anti-D reagents (D-Screen; Diagast, Loss, France).

Article Title: Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles.
Article Snippet: Funding information Guangdong Basic and Applied Basic Research Foundation, Grant/Award Numbers: 2021A1515012139, 2021A1515012532; National Natural Science Foundation of China, Grant/Award Numbers: 81900184, 82070198; The Key Medical Disciplines and Specialties Program of Guangzhou (2021-2023), Guangdong, China Abstract Background: The molecular basis of the D variant phenotype in the Chinese differs greatly from that of the Caucasian.. Adapting a specific D typing strategy to the spectrum of prevalent RHD variant alleles is necessary.. Study Design and Methods: Blood samples with ambiguous D phenotypes were collected in the Southern Chinese population.

Article Title: Abstracts of the 37th International Congress of the ISBT, Virtual meeting, 4-8 June 2022.
Article Snippet: Further RH1 antigen characterization included an anti-RH1 antibody panel containing nine monoclonal antibodies (D-Screen, Diagast).

Article Title: The need for routine detection of the Asian-type DEL allele in individuals with weak or partial D phenotypes from East and Southeast Asian populations.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82470233; Science and Technology Projects in Guangzhou, Grant/Award Numbers: 202201011823, 2024A03J0442, 2023A03J0545, 2023A03J0552; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2024A1515012995 Abstract Background and Objectives: Among the rare serologically D-negative (D ) individuals in Asia, those carrying the Asian-type DEL allele (RHD*DEL1) can be safely managed as D+ individuals during transfusion and pregnancy.. Recently, some individuals carrying RHD*DEL1, who exhibit serologically weak/partial D phenotypes rather than the serologically D phenotype, have also been described.. Whether anti-D alloimmunization can occur among them was explored.

Article Title: The 36th International ISBT Congress, Virtual meeting, 12-16 December 2020.
Article Snippet: The serological characteristic for the epitope of D antigen was further analyzed by using the commercial panel anti-D reagents (D-Screen, Diagast).

Article Title: RHD alleles contributing to serologically weak D phenotypes in China: A single-centre study over 10 years.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 30371312, 81970168; Research Foundation of Shanghai Municipal Health Commission, China, Grant/ Award Number: 201940442 Abstract Background and Objectives: In cases of serologically weak D phenotypes, RHD genotyping may identify discrepant serotyping results and protect the patient against allogeneic immunization.. This study aimed to conduct a comprehensive analysis of weak D alleles in China.. Materials and Methods: We collected samples carrying weak D antigen during a 10-year period from 2005 to 2014.

Article Title: Reduced RhD antigen expression caused by two novel RHD variant alleles.
Article Snippet: R outine donor screening revealed ambiguous results for RhD blood group typing in two donors.. Donor 1, serologically typed as RhD negative, was positive for exon 3/5 and 10 in routine RHD screening as performed for all RhD-negative donors in Switzerland.. Donor 2 displayed an unusual reaction pattern with the Combi Anti-D Mono-Type antisera (clones LDM3 and ESD1) from Medion Grifols Switzerland.

Flow Cytometry:

Article Title: A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants.
Article Snippet: W e report a new RHD variant allele (RHD 1016G>T, Gly339Val, GenBank Accession No. MF737523, ISBT nomenclature RHD*DEL49.) that was discovered in a Korean male hepatocellular carcinoma patient.. We have performed epitope mapping of the D antigen and analyzed the expected effect of this variation with comparison to two other D weak–expressing variants with an amino acid change in the same position.. Pretransfusion testing of D blood group was performed: two commercial anti-D reagents (Ortho Clinical Diagnostics and Millipore) were used for D and weak-D typing, and results indicated no reactions in both routine D and weak-D testing.

Article Title: The 30th Regional Congress of the ISBT, Bangkok, Thailand, 16-19 Nov, 2019.
Article Snippet: RhD phenotyping was initially routinely performed using two monoclonal anti-D reagents (Clone Rum-1, IgM; Clone TH-28/MS26, IgM/IgG), and then tested using a commercial panel of monoclonal anti-D reagents (D-Screen; Diagast, Loss, France).

Article Title: Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles.
Article Snippet: Funding information Guangdong Basic and Applied Basic Research Foundation, Grant/Award Numbers: 2021A1515012139, 2021A1515012532; National Natural Science Foundation of China, Grant/Award Numbers: 81900184, 82070198; The Key Medical Disciplines and Specialties Program of Guangzhou (2021-2023), Guangdong, China Abstract Background: The molecular basis of the D variant phenotype in the Chinese differs greatly from that of the Caucasian.. Adapting a specific D typing strategy to the spectrum of prevalent RHD variant alleles is necessary.. Study Design and Methods: Blood samples with ambiguous D phenotypes were collected in the Southern Chinese population.

Article Title: Abstracts of the 37th International Congress of the ISBT, Virtual meeting, 4-8 June 2022.
Article Snippet: Further RH1 antigen characterization included an anti-RH1 antibody panel containing nine monoclonal antibodies (D-Screen, Diagast).

Article Title: The need for routine detection of the Asian-type DEL allele in individuals with weak or partial D phenotypes from East and Southeast Asian populations.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82470233; Science and Technology Projects in Guangzhou, Grant/Award Numbers: 202201011823, 2024A03J0442, 2023A03J0545, 2023A03J0552; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2024A1515012995 Abstract Background and Objectives: Among the rare serologically D-negative (D ) individuals in Asia, those carrying the Asian-type DEL allele (RHD*DEL1) can be safely managed as D+ individuals during transfusion and pregnancy.. Recently, some individuals carrying RHD*DEL1, who exhibit serologically weak/partial D phenotypes rather than the serologically D phenotype, have also been described.. Whether anti-D alloimmunization can occur among them was explored.

Article Title: The 36th International ISBT Congress, Virtual meeting, 12-16 December 2020.
Article Snippet: The serological characteristic for the epitope of D antigen was further analyzed by using the commercial panel anti-D reagents (D-Screen, Diagast).

Article Title: RHD alleles contributing to serologically weak D phenotypes in China: A single-centre study over 10 years.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 30371312, 81970168; Research Foundation of Shanghai Municipal Health Commission, China, Grant/ Award Number: 201940442 Abstract Background and Objectives: In cases of serologically weak D phenotypes, RHD genotyping may identify discrepant serotyping results and protect the patient against allogeneic immunization.. This study aimed to conduct a comprehensive analysis of weak D alleles in China.. Materials and Methods: We collected samples carrying weak D antigen during a 10-year period from 2005 to 2014.

Article Title: Reduced RhD antigen expression caused by two novel RHD variant alleles.
Article Snippet: R outine donor screening revealed ambiguous results for RhD blood group typing in two donors.. Donor 1, serologically typed as RhD negative, was positive for exon 3/5 and 10 in routine RHD screening as performed for all RhD-negative donors in Switzerland.. Donor 2 displayed an unusual reaction pattern with the Combi Anti-D Mono-Type antisera (clones LDM3 and ESD1) from Medion Grifols Switzerland.

Bioprocessing:

Article Title: A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants.
Article Snippet: W e report a new RHD variant allele (RHD 1016G>T, Gly339Val, GenBank Accession No. MF737523, ISBT nomenclature RHD*DEL49.) that was discovered in a Korean male hepatocellular carcinoma patient.. We have performed epitope mapping of the D antigen and analyzed the expected effect of this variation with comparison to two other D weak–expressing variants with an amino acid change in the same position.. Pretransfusion testing of D blood group was performed: two commercial anti-D reagents (Ortho Clinical Diagnostics and Millipore) were used for D and weak-D typing, and results indicated no reactions in both routine D and weak-D testing.

Article Title: The 30th Regional Congress of the ISBT, Bangkok, Thailand, 16-19 Nov, 2019.
Article Snippet: RhD phenotyping was initially routinely performed using two monoclonal anti-D reagents (Clone Rum-1, IgM; Clone TH-28/MS26, IgM/IgG), and then tested using a commercial panel of monoclonal anti-D reagents (D-Screen; Diagast, Loss, France).

Article Title: Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles.
Article Snippet: Funding information Guangdong Basic and Applied Basic Research Foundation, Grant/Award Numbers: 2021A1515012139, 2021A1515012532; National Natural Science Foundation of China, Grant/Award Numbers: 81900184, 82070198; The Key Medical Disciplines and Specialties Program of Guangzhou (2021-2023), Guangdong, China Abstract Background: The molecular basis of the D variant phenotype in the Chinese differs greatly from that of the Caucasian.. Adapting a specific D typing strategy to the spectrum of prevalent RHD variant alleles is necessary.. Study Design and Methods: Blood samples with ambiguous D phenotypes were collected in the Southern Chinese population.

Article Title: Abstracts of the 37th International Congress of the ISBT, Virtual meeting, 4-8 June 2022.
Article Snippet: Further RH1 antigen characterization included an anti-RH1 antibody panel containing nine monoclonal antibodies (D-Screen, Diagast).

Article Title: The need for routine detection of the Asian-type DEL allele in individuals with weak or partial D phenotypes from East and Southeast Asian populations.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82470233; Science and Technology Projects in Guangzhou, Grant/Award Numbers: 202201011823, 2024A03J0442, 2023A03J0545, 2023A03J0552; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2024A1515012995 Abstract Background and Objectives: Among the rare serologically D-negative (D ) individuals in Asia, those carrying the Asian-type DEL allele (RHD*DEL1) can be safely managed as D+ individuals during transfusion and pregnancy.. Recently, some individuals carrying RHD*DEL1, who exhibit serologically weak/partial D phenotypes rather than the serologically D phenotype, have also been described.. Whether anti-D alloimmunization can occur among them was explored.

Article Title: The 36th International ISBT Congress, Virtual meeting, 12-16 December 2020.
Article Snippet: The serological characteristic for the epitope of D antigen was further analyzed by using the commercial panel anti-D reagents (D-Screen, Diagast).

Article Title: RHD alleles contributing to serologically weak D phenotypes in China: A single-centre study over 10 years.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 30371312, 81970168; Research Foundation of Shanghai Municipal Health Commission, China, Grant/ Award Number: 201940442 Abstract Background and Objectives: In cases of serologically weak D phenotypes, RHD genotyping may identify discrepant serotyping results and protect the patient against allogeneic immunization.. This study aimed to conduct a comprehensive analysis of weak D alleles in China.. Materials and Methods: We collected samples carrying weak D antigen during a 10-year period from 2005 to 2014.

Article Title: Reduced RhD antigen expression caused by two novel RHD variant alleles.
Article Snippet: R outine donor screening revealed ambiguous results for RhD blood group typing in two donors.. Donor 1, serologically typed as RhD negative, was positive for exon 3/5 and 10 in routine RHD screening as performed for all RhD-negative donors in Switzerland.. Donor 2 displayed an unusual reaction pattern with the Combi Anti-D Mono-Type antisera (clones LDM3 and ESD1) from Medion Grifols Switzerland.

Clone Assay:

Article Title: A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants.
Article Snippet: W e report a new RHD variant allele (RHD 1016G>T, Gly339Val, GenBank Accession No. MF737523, ISBT nomenclature RHD*DEL49.) that was discovered in a Korean male hepatocellular carcinoma patient.. We have performed epitope mapping of the D antigen and analyzed the expected effect of this variation with comparison to two other D weak–expressing variants with an amino acid change in the same position.. Pretransfusion testing of D blood group was performed: two commercial anti-D reagents (Ortho Clinical Diagnostics and Millipore) were used for D and weak-D typing, and results indicated no reactions in both routine D and weak-D testing.

Article Title: The 30th Regional Congress of the ISBT, Bangkok, Thailand, 16-19 Nov, 2019.
Article Snippet: RhD phenotyping was initially routinely performed using two monoclonal anti-D reagents (Clone Rum-1, IgM; Clone TH-28/MS26, IgM/IgG), and then tested using a commercial panel of monoclonal anti-D reagents (D-Screen; Diagast, Loss, France).

Article Title: Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles.
Article Snippet: Funding information Guangdong Basic and Applied Basic Research Foundation, Grant/Award Numbers: 2021A1515012139, 2021A1515012532; National Natural Science Foundation of China, Grant/Award Numbers: 81900184, 82070198; The Key Medical Disciplines and Specialties Program of Guangzhou (2021-2023), Guangdong, China Abstract Background: The molecular basis of the D variant phenotype in the Chinese differs greatly from that of the Caucasian.. Adapting a specific D typing strategy to the spectrum of prevalent RHD variant alleles is necessary.. Study Design and Methods: Blood samples with ambiguous D phenotypes were collected in the Southern Chinese population.

Article Title: Abstracts of the 37th International Congress of the ISBT, Virtual meeting, 4-8 June 2022.
Article Snippet: Further RH1 antigen characterization included an anti-RH1 antibody panel containing nine monoclonal antibodies (D-Screen, Diagast).

Article Title: The need for routine detection of the Asian-type DEL allele in individuals with weak or partial D phenotypes from East and Southeast Asian populations.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82470233; Science and Technology Projects in Guangzhou, Grant/Award Numbers: 202201011823, 2024A03J0442, 2023A03J0545, 2023A03J0552; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2024A1515012995 Abstract Background and Objectives: Among the rare serologically D-negative (D ) individuals in Asia, those carrying the Asian-type DEL allele (RHD*DEL1) can be safely managed as D+ individuals during transfusion and pregnancy.. Recently, some individuals carrying RHD*DEL1, who exhibit serologically weak/partial D phenotypes rather than the serologically D phenotype, have also been described.. Whether anti-D alloimmunization can occur among them was explored.

Article Title: The 36th International ISBT Congress, Virtual meeting, 12-16 December 2020.
Article Snippet: The serological characteristic for the epitope of D antigen was further analyzed by using the commercial panel anti-D reagents (D-Screen, Diagast).

Article Title: RHD alleles contributing to serologically weak D phenotypes in China: A single-centre study over 10 years.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 30371312, 81970168; Research Foundation of Shanghai Municipal Health Commission, China, Grant/ Award Number: 201940442 Abstract Background and Objectives: In cases of serologically weak D phenotypes, RHD genotyping may identify discrepant serotyping results and protect the patient against allogeneic immunization.. This study aimed to conduct a comprehensive analysis of weak D alleles in China.. Materials and Methods: We collected samples carrying weak D antigen during a 10-year period from 2005 to 2014.

Article Title: Reduced RhD antigen expression caused by two novel RHD variant alleles.
Article Snippet: R outine donor screening revealed ambiguous results for RhD blood group typing in two donors.. Donor 1, serologically typed as RhD negative, was positive for exon 3/5 and 10 in routine RHD screening as performed for all RhD-negative donors in Switzerland.. Donor 2 displayed an unusual reaction pattern with the Combi Anti-D Mono-Type antisera (clones LDM3 and ESD1) from Medion Grifols Switzerland.

Adsorption:

Article Title: A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants.
Article Snippet: W e report a new RHD variant allele (RHD 1016G>T, Gly339Val, GenBank Accession No. MF737523, ISBT nomenclature RHD*DEL49.) that was discovered in a Korean male hepatocellular carcinoma patient.. We have performed epitope mapping of the D antigen and analyzed the expected effect of this variation with comparison to two other D weak–expressing variants with an amino acid change in the same position.. Pretransfusion testing of D blood group was performed: two commercial anti-D reagents (Ortho Clinical Diagnostics and Millipore) were used for D and weak-D typing, and results indicated no reactions in both routine D and weak-D testing.

Article Title: The 30th Regional Congress of the ISBT, Bangkok, Thailand, 16-19 Nov, 2019.
Article Snippet: RhD phenotyping was initially routinely performed using two monoclonal anti-D reagents (Clone Rum-1, IgM; Clone TH-28/MS26, IgM/IgG), and then tested using a commercial panel of monoclonal anti-D reagents (D-Screen; Diagast, Loss, France).

Article Title: Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles.
Article Snippet: Funding information Guangdong Basic and Applied Basic Research Foundation, Grant/Award Numbers: 2021A1515012139, 2021A1515012532; National Natural Science Foundation of China, Grant/Award Numbers: 81900184, 82070198; The Key Medical Disciplines and Specialties Program of Guangzhou (2021-2023), Guangdong, China Abstract Background: The molecular basis of the D variant phenotype in the Chinese differs greatly from that of the Caucasian.. Adapting a specific D typing strategy to the spectrum of prevalent RHD variant alleles is necessary.. Study Design and Methods: Blood samples with ambiguous D phenotypes were collected in the Southern Chinese population.

Article Title: Abstracts of the 37th International Congress of the ISBT, Virtual meeting, 4-8 June 2022.
Article Snippet: Further RH1 antigen characterization included an anti-RH1 antibody panel containing nine monoclonal antibodies (D-Screen, Diagast).

Article Title: The need for routine detection of the Asian-type DEL allele in individuals with weak or partial D phenotypes from East and Southeast Asian populations.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82470233; Science and Technology Projects in Guangzhou, Grant/Award Numbers: 202201011823, 2024A03J0442, 2023A03J0545, 2023A03J0552; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2024A1515012995 Abstract Background and Objectives: Among the rare serologically D-negative (D ) individuals in Asia, those carrying the Asian-type DEL allele (RHD*DEL1) can be safely managed as D+ individuals during transfusion and pregnancy.. Recently, some individuals carrying RHD*DEL1, who exhibit serologically weak/partial D phenotypes rather than the serologically D phenotype, have also been described.. Whether anti-D alloimmunization can occur among them was explored.

Article Title: The 36th International ISBT Congress, Virtual meeting, 12-16 December 2020.
Article Snippet: The serological characteristic for the epitope of D antigen was further analyzed by using the commercial panel anti-D reagents (D-Screen, Diagast).

Article Title: RHD alleles contributing to serologically weak D phenotypes in China: A single-centre study over 10 years.
Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 30371312, 81970168; Research Foundation of Shanghai Municipal Health Commission, China, Grant/ Award Number: 201940442 Abstract Background and Objectives: In cases of serologically weak D phenotypes, RHD genotyping may identify discrepant serotyping results and protect the patient against allogeneic immunization.. This study aimed to conduct a comprehensive analysis of weak D alleles in China.. Materials and Methods: We collected samples carrying weak D antigen during a 10-year period from 2005 to 2014.

Article Title: Reduced RhD antigen expression caused by two novel RHD variant alleles.
Article Snippet: R outine donor screening revealed ambiguous results for RhD blood group typing in two donors.. Donor 1, serologically typed as RhD negative, was positive for exon 3/5 and 10 in routine RHD screening as performed for all RhD-negative donors in Switzerland.. Donor 2 displayed an unusual reaction pattern with the Combi Anti-D Mono-Type antisera (clones LDM3 and ESD1) from Medion Grifols Switzerland.



Similar Products

96
New England Biolabs phage display screen
Phage Display Screen, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+screen/Ph%2ED%2E-12+Phage+Display+Peptide+Library/pm41076461-165-0-16
Average 96 stars, based on 1 article reviews
phage display screen - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

96
Revvity opera phenix d ow
Opera Phenix D Ow, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+screen/Opera+Phenix+Plus+high-content+screening+system/10__1158_slash_1078___0432__ccr___25___0950-137-5-21
Average 96 stars, based on 1 article reviews
opera phenix d ow - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

90
Diagast Inc monoclonal anti-d reagents d-screen
Monoclonal Anti D Reagents D Screen, supplied by Diagast Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+screen/monoclonal+anti+d+d+screen/pm40389221-75-13-16
Average 90 stars, based on 1 article reviews
monoclonal anti-d reagents d-screen - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Merck KGaA pellicon 3 tff cassettes with d-screen with 30 kd ultracel® membranes
Pellicon 3 Tff Cassettes With D Screen With 30 Kd Ultracel® Membranes, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+screen/concentrators+with+30+kd+cut+off/pm40241106-54-5-11
Average 90 stars, based on 1 article reviews
pellicon 3 tff cassettes with d-screen with 30 kd ultracel® membranes - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

86
Quest Diagnostics screening 25 oh d
Screening 25 Oh D, supplied by Quest Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+screen/25+d+hydroxy+serum+vitamin/pm38481375-57-1-3
Average 86 stars, based on 1 article reviews
screening 25 oh d - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Quest Diagnostics screening serum 25 oh d levels
Screening Serum 25 Oh D Levels, supplied by Quest Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+screen/25+d+hydroxy+serum+vitamin/pm38481375-56-1-5
Average 86 stars, based on 1 article reviews
screening serum 25 oh d levels - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
Millipore membranes used for tangential flow filtration 30 kda d screen 0.57 m2
Membranes Used For Tangential Flow Filtration 30 Kda D Screen 0.57 M2, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+screen/membranes+used+for+tangential+flow+filtration+30+kda+d+screen+0+57+m2/pm39427713-60-0-15
Average 90 stars, based on 1 article reviews
membranes used for tangential flow filtration 30 kda d screen 0.57 m2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Merck KGaA 0.57 m2 ultracel pellicon 3 d screen
0.57 M2 Ultracel Pellicon 3 D Screen, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+screen/0+57+m2+ultracel+pellicon+3+d+screen/pm39385541-56-15-21
Average 90 stars, based on 1 article reviews
0.57 m2 ultracel pellicon 3 d screen - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Diagast Inc d-screen identification kit
D Screen Identification Kit, supplied by Diagast Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+screen/d+screen+identification+kit/pm39385525-13-16-19
Average 90 stars, based on 1 article reviews
d-screen identification kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Quidel d 3 ultra 8 dfa respiratory virus screening and id kit
D 3 Ultra 8 Dfa Respiratory Virus Screening And Id Kit, supplied by Quidel, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+screen/d+3+dfa+cytomegalovirus+immediate+early+antigen+identification+kit/pm39163959-272-39-41
Average 90 stars, based on 1 article reviews
d 3 ultra 8 dfa respiratory virus screening and id kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results